X0306 4 2020-11-13 0 0001640428 EverQuote, Inc. EVER 0001744445 Auguste Darryl C/O EVERQUOTE, INC. 210 BROADWAY CAMBRIDGE MA 02139 1 1 0 0 See Remarks Class A Common Stock 2020-11-13 4 M 0 10000 6.89 A 66597 D Class A Common Stock 2020-11-13 4 M 0 11553 4.82 A 78150 D Class A Common Stock 2020-11-13 4 S 0 24152 40.56 D 53998 D Employee Stock Option (right to buy) 6.89 2020-11-13 4 D 0 10000 0.00 D 2026-01-10 Class B Common Stock 10000 70000 D Employee Stock Option (right to buy) 6.89 2020-11-13 4 A 0 10000 0.00 A 2026-01-10 Class A Common Stock 10000 10000 D Employee Stock Option (right to buy) 6.89 2020-11-13 4 M 0 10000 0.00 D 2026-01-10 Class A Common Stock 10000 0 D Employee Stock Option (right to buy) 4.82 2020-11-13 4 D 0 11553 0.00 D 2025-02-25 Class B Common Stock 11553 44447 D Employee Stock Option (right to buy) 4.82 2020-11-13 4 A 0 11553 0.00 A 2025-02-25 Class A Common Stock 11553 11553 D Employee Stock Option (right to buy) 4.82 2020-11-13 4 M 0 11553 0.00 D 2025-02-25 Class A Common Stock 11553 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.23 to $41.03, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on January 11, 2016 and was exercisable for up to an aggregate total of 80,000 shares of Class B Common Stock, which shares vest over six years in seventy-two equal monthly installments with the first installment vested on February 28, 2017. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on February 26, 2015 and was exercisable for up to an aggregate total of 56,000 shares of Class B Common Stock, which shares fully vested as of February 26, 2019. The replacement option is exercisable for shares of Class A Common Stock for the number of shares exercised in this transaction. Executive Vice President of Strategic Projects /s/ David Mason, as attorney-in-fact for Darryl Auguste 2020-11-17